CT Indexes of Emphysema and Airways in Healthy Volunteers: Normal Values; Relations With Gender, Height and Weight

November 19, 2015 updated by: Erasme University Hospital
Various indexes have been proposed to quantify both pulmonary emphysema and airways disease on chest CT scans. It is unknown whether these indexes should be consider in absolute values or as compared to predicted normal values. The purposes of the present study is thus : a) to measure these indexes at CT in healthy volunteers; b) to investigate their relations with gender, height and weight.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

87 healthy volunteers performed consecutively a low-dose chest CT scan and pulmonary function tests:

  1. On chest CT scans, indexes reflecting pulmonary emphysema and airways measurements have been computed by using dedicated softwares. Each of our three readers performed two reading sessions.

    Relative area of lung parenchyma with attenuation value less than -960 Hounsfield Units; luminal area and wall thickness in third and fourth generations airways were recorded.

  2. Pulmonary function tests were performed: vital capacity, forced vital capacity , functional residual capacity, total lung capacity, residual volume, forced expiratory volume in one second, and diffusion lung capacity for carbon monoxide were recorded (either in absolute values and percentage of predicted values).

CT indexes were compared with gender, height and weight.

Study Type

Observational

Enrollment (Actual)

87

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1070
        • Erasme University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy Volunteers

Description

Inclusion Criteria:

  • Never smoked.
  • No respiratory infection in the 4 weeks before the begin of the study.
  • No history of pulmonary resection.
  • No active malignancy or malignancy of any organ system within the past 5 years.

Exclusion Criteria:

  • no exclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy Volunteers

Inclusion criteria:

  1. Aged 18 or more.
  2. Never smoked.
  3. No respiratory infection in the 4 weeks before the begin of the study.
  4. No history of pulmonary resection.
  5. No active malignancy or malignancy of any organ system within the past 5 years.

Supine chest CT scan after full inspiration. Acquisition parameters: (Topogram 35 mA 120 kV 512 mm length)

35 quality ref mAs with care-dose ON 120 kV Pitch 1.4 Rotation time 0.33 s Acquired images 64 x 0.6 mm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CT index - RA960 (%)
Time Frame: 4 hours
From acquired data, images were reconstructed using a soft algorithm. On these soft images, the relative area of lung parenchyma with attenuation value less than -960 Hounsfield Units was computed (expressed in %), as an index representative of pulmonary emphysema extent.
4 hours
CT index - LA3rd (mm2)
Time Frame: 4 hours
From acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway lumen was measured in third generations of airways (expressed in mm2).
4 hours
CT index - LA4th (mm2)
Time Frame: 4 hours
From acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway lumen was measured in fourth generations of airways (expressed in mm2).
4 hours
CT index - WT3rd (mm)
Time Frame: 4 hours
From acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway wall was measured in third generations of airways (expressed in mm).
4 hours
CT index - WT4th (mm)
Time Frame: 4 hours
From acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway wall was measured in fourth generations of airways (expressed in mm).
4 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulmonary function tests - VC (l)
Time Frame: 4 hours
Vital capacity was measured (expressed in l).
4 hours
Pulmonary function tests - FVC (l)
Time Frame: 4 hours
Forced vital capacity was measured (expressed in l).
4 hours
Pulmonary function tests - FRC (l)
Time Frame: 4 hours
Functional residual capacity capacity was measured (expressed in l).
4 hours
Pulmonary function tests - TLC (l)
Time Frame: 4 hours
Total lung capacity was measured (expressed in l).
4 hours
Pulmonary function tests - RV (l)
Time Frame: 4 hours
Residual volume was measured (expressed in l).
4 hours
Pulmonary function tests - FEV1 (l)
Time Frame: 4 hours
Forced expiratory volume in one second was measured (expressed in l).
4 hours
Pulmonary function tests - DLCO (ml/min/ mmHg)
Time Frame: 4 hours
Diffusion lung capacity for carbon monoxide was measured (expressed in ml/min/ mmHg)
4 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2010

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

October 30, 2015

First Submitted That Met QC Criteria

November 19, 2015

First Posted (Estimate)

November 23, 2015

Study Record Updates

Last Update Posted (Estimate)

November 23, 2015

Last Update Submitted That Met QC Criteria

November 19, 2015

Last Verified

November 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Low-dose chest CT scans

3
Subscribe